President Donald Trump has announced the forthcoming launch of a government-run website named TrumpRx, designed to help Americans purchase medications at reduced prices. Scheduled to go live in 2026, the website aims to direct consumers to online discounts offered by pharmaceutical companies, including Pfizer.
This announcement follows a three-year agreement with Pfizer, during which the company will receive a reprieve from tariffs in exchange for committing to invest in U.S.-based manufacturing. As part of the deal, Pfizer has also agreed to lower prices on most primary care medications sold through state Medicaid programs, potentially leading to an average savings of 50 percent for patients.
While specific details about the TrumpRx website remain limited, senior officials have indicated that it will direct users to the websites of pharmaceutical companies for order placement. Notably, only patients without health insurance will be eligible to access these discounts. Reports suggest that Trump has established similar arrangements with other pharmaceutical companies, though no specific names have been released.
As the TrumpRx initiative develops, questions remain regarding its implementation and the breadth of partnerships with additional drug manufacturers.
Source: https://www.theverge.com/news/790156/trump-healthcare-government-website-trumprx-pfizer